this piece corresponds to the legacy myPDB login in the form of a bootstrap modal, will likely retire-->

TFP

10-[3-(4-METHYL-PIPERAZIN-1-YL)-PROPYL]-2-TRIFLUOROMETHYL-10H-PHENOTHIAZINE

TFP is found in 7 entries

TFP as free ligands, exist in 7 entries. Example includes: 1WRL 1CTR 1LIN

Find related ligands: Stereoisomers Similar ligands Chemical Structure Search

View summary at Ligand Expo



Chemical Component Summary

Name10-[3-(4-METHYL-PIPERAZIN-1-YL)-PROPYL]-2-TRIFLUOROMETHYL-10H-PHENOTHIAZINE
Identifiers10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)phenothiazine
FormulaC21 H24 F3 N3 S
Molecular Weight407.50 g/mol
TypeNON-POLYMER
Isomeric SMILESCN1CCN(CCCN2c3ccccc3Sc3ccc(cc23)C(F)(F)F)CC1
InChIInChI=1S/C21H24F3N3S/c1-25-11-13-26(14-12-25)9-4-10-27-17-5-2-3-6-19(17)28-20-8-7-16(15-18(20)27)21(22,23)24/h2-3,5-8,15H,4,9-14H2,1H3
InChIKeyZEWQUBUPAILYHI-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count52
Chiral Atom Count0
Chiral Atomsn/a
Bond Count55
Aromatic Bond Count12
Leaving Atomsn/a

Drug Info: DrugBank

DrugBank IDDB00831 Different stereochemistry
NameTrifluoperazine
Groupsapproved
DescriptionA phenothiazine with actions similar to chlorpromazine. It is used as an antipsychotic and an antiemetic. [PubChem]
Synonyms
  • 10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine
  • 10-[3-(4-METHYL-piperazin-1-yl)-propyl]-2-trifluoromethyl-10H-phenothiazine
  • Trifluoperazina
  • Trifluoperazine
  • Trifluoperazinum
SaltsTrifluoperazine Hydrochloride
Brand Names
  • Novo-flurazine Tab 1mg
  • Novo-flurazine Tab 20mg
  • Novo-trifluzine - Tab 10mg
  • Novo-trifluzine - Tab 2mg
Affected OrganismHumans and other mammals
IndicationFor the treatment of anxiety disorders, depressive symptoms secondary to anxiety and agitation.
PharmacologyTrifluoperazine is a trifluoro-methyl phenothiazine derivative intended for the management of schizophrenia and other psychotic disorders. Trifluoperazine has not been shown effective in the management of behaviorial complications in patients with mental retardation.
Mechanism of actionTrifluoperazine blocks postsynaptic mesolimbic dopaminergic D1 and D2 receptors in the brain; depresses the release of hypothalamic and hypophyseal hormones and is believed to depress the reticular activating system thus affecting basal metabolism, body temperature, wakefulness, vasomotor tone, and emesis.
Route of administrationOral
Categories
  • Alpha1 Antagonists
  • Antiemetics
  • Antipsychotic Agents
  • Antipsychotic Agents (First Generation [Typical])
  • Autonomic Agents
ATC-CodeN05AB06
AHFS-Code28:16.08.24
CAS number117-89-5
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682